Header image

Roundtable 2: Using imaging to parse through heterogeneity and identify biomarkers associated with cognition and functioning in neurodevelopmental and related disorders.

Monday, June 10, 2024
1:20 PM - 1:40 PM
214

Overview

Dr. Stephanie Ameis


Details

By the end of this session, participants will be able to: •Describe a brief overview of imaging research advances and challenges of identifying brain markers related to behavioural outcomes of importance to individuals with neurodevelopmental conditions. •Review how the use of deep phenotyping including imaging, clinical, cognitive, and other markers can be leveraged in heterogeneous samples to identify subgroups with shared brain-behaviour profiles that may have similar outcomes and may respond similarly to interventions. •Review the necessary steps needed to validate identified markers to jumpstart downstream treatment innovation research


Speaker

Dr. Stephanie Ameis

Biomarkers Roundtable

loading